Ice Miller Attorney Martha O’Connor Joins the Juvenile Diabetes Research Foundation Young Leadership Ice Miller Attorney Martha O’Connor Joins the Juvenile Diabetes Research Foundation Young Leadership

Ice Miller Attorney Martha O’Connor Joins the Juvenile Diabetes Research Foundation Young Leadership Committee

Ice Miller LLP is pleased to announce that attorney Martha O’Connor has joined the Juvenile Diabetes Research Foundation Young Leadership Committee. The committee hosts numerous fundraising, networking and social events in Chicago to help create awareness of Type 1 Diabetes and fund research aimed at turning type One into Type None.
 
Martha O’Connor is an attorney in Ice Miller’s Litigation Group, and handles class actions, construction law and other matters.  Through her experiences, she has developed skills to successfully deal with the frequent challenges in commercial litigation. She graduated cum laude from Northwestern Law in 2013 where she was on the staff of Northwestern’s Journal of International Law and Business. She is a summa cum laude graduate of Bowling Green State University. Prior to joining Ice Miller, Martha was an associate at the Chicago office of an international law firm, where she began her practice. 
 
###
 
About Ice Miller LLP
Founded in 1910, Ice Miller LLP is an Am Law 200 Firm with a nationally recognized reputation in many of its practice areas. Ice Miller offers a broad array of capabilities in virtually all areas of legal practice including: corporate, patents and trademarks, bankruptcy, lobbying, labor and employment, litigation, employee benefits, environment, tax, trusts and estates, real estate, municipal finance, public affairs and government law. With offices in Chicago; Cleveland; Columbus; DuPage County, Ill.; Indianapolis; New York; and Washington, D.C., the Firm has more than 300 lawyers and 40 paraprofessionals.  Visit icemiller.com for more information.
 
About Juvenile Diabetes Research Foundation
JDRF is the leading global organization funding type 1 diabetes (T1D) research. Our mission is to accelerate life-changing breakthroughs to cure, prevent and treat T1D and its complications. To accomplish this, JDRF has invested nearly $2 billion in research funding since our inception. We are an organization built on a grassroots model of people connecting in their local communities, collaborating regionally for efficiency and broader fundraising impact, and uniting on a national stage to pool resources, passion, and energy. We collaborate with academic institutions, policymakers, and corporate and industry partners to develop and deliver a pipeline of innovative therapies to people living with T1D. Our staff and volunteers in more than 100 locations throughout the United States and our six international affiliates are dedicated to advocacy, community engagement and our vision of a world without T1D. For more information, please visit jdrf.org or follow us on Twitter: @JDRF.
 
View Full Site View Mobile Optimized